Achaogen’s plazomicin and levofloxacin safe and effective in treating cUTI, acute pyelonephritis – News-Medical.Net

Achaogen, Inc. announced today that all objectives were met in the company’s multi-national Phase 2 study of plazomicin compared to levofloxacin for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis in adults.

Leave a Reply

Your email address will not be published.

*